Bioavailability of Chemopreventive and Nutritional Compounds in Broccoli
NCT ID: NCT01743924
Last Updated: 2012-12-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
7 participants
INTERVENTIONAL
2011-07-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research Methods \& Procedures A cross-over-design study of 7 subjects after ingestion of 200-g raw or microwaved kailan-hybrid broccoli was conducted. Total ITC equivalents in the vegetable, urine and blood samples were determined by HPLC as the cyclocondensation product of 1,2-benzenedithiol.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Raw
Broccoli,200 grams
raw broccoli
To eat this plant material
cooked
Microwaved, 200 grams
raw broccoli
To eat this plant material
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
raw broccoli
To eat this plant material
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects age: 22-50 years-old.
* Good health of subjects: confirmed by medical history, physical examination and clinical laboratory analysis of urine and blood (complete blood count and liver function markers including serum glutamic-pyruvic transaminase bilirubin test and glucose-6-phosphate dehydrogenase).
Exclusion Criteria
* Use of regular medications.
* Had taken antibiotics for 4 weeks immediately preceding the study.
* History of kidney stones, diabetes mellitus, bleeding disorders or family history of iron overload/hemochromatosis.
22 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario Reina Sofia de Cordoba
OTHER_GOV
Universidad Politécnica de Cartagena
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ginés Benito Martínez Hernández
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Concepcion Maeztu Sardiña, Doctor
Role: STUDY_CHAIR
Comité ético de investigación clínica
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital General Universitario Reina Sofía
Murcia, Murcia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Broccoli_Bioav.
Identifier Type: -
Identifier Source: org_study_id